Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Bromo-1-methyl-1H-indazol-3-amine is a chemical compound with the molecular formula C9H8BrN3, belonging to the indazole class of heterocyclic aromatic organic compounds. It is a derivative known for its potential in medicinal chemistry, particularly for the synthesis of biologically active compounds and pharmaceutical drugs. Its structural characteristics and pharmacological properties make it a valuable building block in the development of anticancer and antimicrobial agents.

1214899-85-0

Post Buying Request

1214899-85-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1214899-85-0 Usage

Uses

Used in Medicinal Chemistry:
6-Bromo-1-methyl-1H-indazol-3-amine is used as a key intermediate in the synthesis of various biologically active compounds for medicinal applications, leveraging its unique structural features to enhance the potency and selectivity of resulting pharmaceuticals.
Used in Pharmaceutical Drug Development:
6-Bromo-1-methyl-1H-indazol-3-amine serves as a building block in the development of new pharmaceutical drugs, particularly those targeting cancer and microbial infections, due to its potential to contribute to the creation of effective and novel therapeutic agents.
Used in Anticancer Research:
6-Bromo-1-methyl-1H-indazol-3-amine is used as a precursor in the design and synthesis of potential anticancer agents, aiming to develop drugs that can target and combat cancer cells more effectively.
Used in Antimicrobial Research:
6-Bromo-1-methyl-1H-indazol-3-amine is also utilized in antimicrobial research, where it is employed to create new agents capable of combating resistant strains of bacteria and other pathogens, contributing to the fight against antibiotic resistance.
Used in Organic Synthesis:
6-Bromo-1-methyl-1H-indazol-3-amine is used as a versatile reagent in organic synthesis, enabling the creation of a wide range of chemical products and intermediates for various applications in the chemical industry.
Used in Drug Discovery:
In the field of drug discovery, 6-Bromo-1-methyl-1H-indazol-3-amine is used to explore new chemical entities with potential therapeutic benefits, contributing to the advancement of medical treatments and healthcare solutions.

Check Digit Verification of cas no

The CAS Registry Mumber 1214899-85-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,8,9 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1214899-85:
(9*1)+(8*2)+(7*1)+(6*4)+(5*8)+(4*9)+(3*9)+(2*8)+(1*5)=180
180 % 10 = 0
So 1214899-85-0 is a valid CAS Registry Number.

1214899-85-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Bromo-1-methyl-1H-indazol-3-amine

1.2 Other means of identification

Product number -
Other names 6-bromo-1-methylindazol-3-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1214899-85-0 SDS

1214899-85-0Relevant articles and documents

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

-

Page/Page column 362-363, (2021/06/26)

The invention provides compounds that degrade the epidermal growth factor receptor (EGFR) including mutant forms via the ubiquitination of the EGFR protein and subsequent proteasomal degradation. The compounds are useful for the treatment of various cancers.

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19

Mallinger, Aurélie,Schiemann, Kai,Rink, Christian,Stieber, Frank,Calderini, Michel,Crumpler, Simon,Stubbs, Mark,Adeniji-Popoola, Olajumoke,Poeschke, Oliver,Busch, Michael,Czodrowski, Paul,Musil, Djordje,Schwarz, Daniel,Ortiz-Ruiz, Maria-Jesus,Schneider, Richard,Thai, Ching,Valenti, Melanie,De Haven Brandon, Alexis,Burke, Rosemary,Workman, Paul,Dale, Trevor,Wienke, Dirk,Clarke, Paul A.,Esdar, Christina,Raynaud, Florence I.,Eccles, Suzanne A.,Rohdich, Felix,Blagg, Julian

, p. 1078 - 1101 (2016/02/23)

The Mediator complex-associated cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene. Here we report the discovery of 109 (CCT251921), a potent, selective, and orally bioavailable inhibitor of CDK8 with equipotent affinity for CDK19. We describe a structure-based design approach leading to the discovery of a 3,4,5-trisubstituted-2-aminopyridine series and present the application of physicochemical property analyses to successfully reduce in vivo metabolic clearance, minimize transporter-mediated biliary elimination while maintaining acceptable aqueous solubility. Compound 109 affords the optimal compromise of in vitro biochemical, pharmacokinetic, and physicochemical properties and is suitable for progression to animal models of cancer.

HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES

-

Paragraph 000304, (2016/05/02)

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.

AMINOINDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS

-

Page/Page column 23, (2016/10/11)

The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav1.7, to compositions containing said derivatives and processes for their preparation.

A general, one-step synthesis of substituted indazoles using a flow reactor

Wheeler, Rob C.,Baxter, Emma,Campbell, Ian B.,MacDonald, Simon J. F.

experimental part, p. 565 - 569 (2011/12/02)

Flow chemistry is a rapidly emerging technology within the pharmaceutical industry, both within medicinal and development chemistry groups. The advantages of flow chemistry, increased safety, improved reproducibility, enhanced scalability, are readily apparent, and we aimed to exploit this technology in order to provide small amounts of pharmaceutically interesting fragments via a safe and scalable route, which would enable the rapid synthesis of multigram quantities on demand. Here we report a general and versatile route which utilises flow chemistry to deliver a range of known and novel indazoles, including 3-amino and 3-hydroxy analogues.

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

-

Page/Page column 118, (2010/06/11)

This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1214899-85-0